Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases.
PR was most often positive in pancreatic NET and only rarely in non-pancreatic NET.
»
03/16/16
The Association Between Unwanted Sexual Experiences and Early-Onset Cervical Cancer and Precancer by Age 25: A Case-Control Study.
Prevalence of childhood genital contact abuse in cases with cervical cancer was 45.5%.
»
11/18/16
Epidemiology for primary brain tumors: a nationwide population-based study.
First study to describe incidence rates and epidemiological data for all histological subtypes of PCNST.
»
06/14/16
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.
Loss of KCNQ1 protein expression from epithelial cells was strongly associated with poor DFS.
»
06/29/16
Differential regulation of the melanoma proteome by eIF4A1 and eIF4E.
Effects of eIF4A1 and eIF4E on translation are mediated by the coding region and 3'UTR.
»
11/16/16
Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.
Cetuximab inhibited migration, invasion, epithelial-mesenchymal transition, and lymph node metastasis by suppressing EGFR-GEP100-Arf6-AMAP1 pathway.
»
12/29/15
Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
Expression of S100A4 was down-regulated by simvastatin.
»
12/08/15
microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
The strongest inhibitory miRNA, miR-137, suppressed the activity of a luciferase reporter gene.
»
06/10/16
CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
CMTM3 inhibits the EGF-mediated tumorigenicity of gastric cancer cells via enhancing Rab5 activity.
»
08/04/16
KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer.
Secondary effects of a mutation can have a higher prognostic relevance than the primary genetic alteration itself.
»
09/11/16
< Prev
Next >